
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Fosphenytoin sodium injection, USP, can be used to treat and prevent seizures during neurosurgery as well as to control generalized convulsive status epilepticus.
It can also be used in place of oral phenytoin for short periods of time. 1.5 mg of fosphenytoin sodium, or "1 mg phenytoin sodium equivalents," is the same as 1 mg of phenytoin sodium.
Fosphenytoin concentration and quantity are always expressed in mg PE.A 1,000-mg PE dose of fosphenytoin is equivalent to a 1,000-mg dose of phenytoin, or fosphenytoin 15 to 20 mg PE/kg is equivalent to phenytoin 15 to 20 mg/kg.
Fosphenytoin should not be given faster than 150 mg PE/min due to the risk of severe hypotension and cardiac arrhythmias;examine THE Monitoring, Precautions, and Administration Rate.
The Global Fosphenytoin sodium injection market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
An abbreviated new drug application (ANDA) for fosphenytoin sodium injection USP, 100 mg/2mL and 500 mg/10mL (equivalent to phenytoin sodium), has been approved by the FDA in the United States.
A prodrug of phenytoin sodium called fosphenytoin sodium injection is approved for short-term use to prevent and control generalized seizures that occur during neurosurgery.
Parenterally, the drug metabolizes into the active metabolite phenytoin sodium as a prodrug.
Akorn, Inc. and Strides Arcolab jointly fund the manufacturing of this drug's variant.The US-based company Acorn makes and sells sterile specialty pharmaceuticals.
One of the largest exporters of brand-name generic pharmaceuticals from India, Strides Arcolab Ltd has manufacturing facilities in the United States, Brazil, Mexico, Italy, Poland, Singapore, and India.
Additionally, the portfolio of the joint venture includes 53 product line offerings and 29 ANDAs.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2022-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2022-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2022-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2022-2030 |
21 | Product installation rate by OEM, 2022 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2022 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |